MassDevice.com +5 | The top 5 medtech stories for September 15, 2016

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Former St. Jude exec Craig seeks Minn. Congressional seat Former St. Jude Medical HR executive Angie Craig is looking to take a seat in Minnesota’s 2nd Congressional district for Democrats this year in a closely watched race. Craig is facing off against libertarian talk-show host Jason Lewis (R) for the seat held by Rep. John Kline (R), who’s retiring after 14 years on Capitol Hill. Read more 4. High-capacity nanoparticle holds potential for targeted cancer therapies Chemists from the Mass. Institute of Technology developed a nanoparticle that they can pack with 3 or more drugs to create custom combination therapies for cancer, according to a study published this week in the Journal of the American Chemical Society. The team also revealed that cisplatin, a powerful anti-cancer drug, doesn’t work using the same DNA-damaging mechanism when delivered via nanoparticle compared to traditional methods. Read more 3. Hologram tech allows surgeons to manipulate images within sterile field NZ Technologies Tipso, a Vancouver-based technology firm, developed ...
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 5 Source Type: news

Related Links:

(Mayo Clinic) Patients diagnosed with pancreatic cancer can develop elevated blood sugar levels up to three years before their cancer diagnosis, according to the results of a study by Mayo Clinic researchers published the journal Gastroenterology.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
Introduction: Hyperglycaemia is a significant cause of morbidity in cancer patients accounting for up to 5% of emergency oncology admissions (1). The incidence of hyperglycaemia in non-diabetic patients receiving anti-cancer therapy has been shown to be as high as 11.6% (2). One significant factor is the high doses of steroids administered either as part of the systemic anti-cancer treatment to control nausea and vomiting, or to palliate other cancer-related symptoms such as pain or anorexia. Patients with gastro-intestinal (GI) malignancies, in particular, often receive high doses of steroids as part of their chemotherapy...
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research
Introduction: Type 2 diabetes mellitus is likely the third modifiable risk factor for pancreatic cancer (PDAC) after cigarette smoking and obesity. Epidemiological investigations have found that long-term type 2 diabetes mellitus is associated with a 1.5- to 2.0-fold increase in the risk of PDAC. On the other hand, new-onset diabetes may indicate subclinical PDAC, and patients with new-onset diabetes may constitute a population in whom PDAC can be detected early. Use of the antidiabetic drugs, such as metformin, has been associated with reduced risk of PDAC in diabetics and recognized as an antitumor agent with the potenti...
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research
Latinos, African - Americans with recent - onset disease have higher risk than those with long - term disease
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Internal Medicine, Oncology, Journal, Source Type: news
TUESDAY, June 19, 2018 -- Recent-onset diabetes is associated with more than a two-fold greater increase in risk of pancreatic cancer (PC) than long-standing diabetes in African-Americans and Latinos, according to a study published online June 18 in...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
The onset of diabetes in people over 50 years old may be an indicator of pancreatic cancer, according to research published in theJournal of the National Cancer Institute.CNN
Source: Society for Endocrinology - Category: Endocrinology Source Type: news
African Americans and Latinos with recent-onset diabetes have a much higher risk of developing pancreatic cancer than their counterparts without diabetes.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Recent-onset type 2 diabetes has been linked to pancreatic cancer in African Americans and Hispanics older than 50, according to a study.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news
Recent-onset type 2 diabetes has been linked to pancreatic cancer in African Americans and Hispanics older than 50, according to a study.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news
University of Southern California researchers claim being diagnosed with type 2 diabetes after the age of 50 could be a sign of pancreatic cancer as rates are higher than in long-term diabetics.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Therapy | Chemistry | Diabetes | Endocrinology | Hospitals | Medical Devices | Men | Nanotechnology | Pancreas | Pancreatic Cancer | Politics | Radiology | Study